48,460
edits
Difference between revisions of "Small cell carcinoma of the lung"
Jump to navigation
Jump to search
Small cell carcinoma of the lung (view source)
Revision as of 21:53, 10 December 2021
, 21:53, 10 December 2021→Possible LCNEC: tweak
(→Possible LCNEC: tweak) |
|||
| (9 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
| Subtypes = large cell neuroendocrine carcinoma (LCNEC) | | Subtypes = large cell neuroendocrine carcinoma (LCNEC) | ||
| LMDDx = poorly differentiated [[adenocarcinoma of the lung]], [[atypical carcinoid]], [[lung carcinoid]], metastatic [[small cell carcinoma]], [[lymphoma]], other [[small round blue cell tumours]] | | LMDDx = poorly differentiated [[adenocarcinoma of the lung]], [[atypical carcinoid]], [[lung carcinoid]], metastatic [[small cell carcinoma]], [[lymphoma]], other [[small round blue cell tumours]] | ||
| Stains = chromogranin +ve, synaptophysin +ve, CD56 +ve, NSE +ve, TTF-1 +ve | | Stains = | ||
| IHC = chromogranin +ve, synaptophysin +ve, CD56 +ve, NSE +ve, TTF-1 +ve, Ki-67 (>50%) | |||
| EM = | | EM = | ||
| Molecular = | | Molecular = | ||
| Line 99: | Line 99: | ||
*Synaptophysin +ve. | *Synaptophysin +ve. | ||
**May be very weak. | **May be very weak. | ||
*TTF-1 +ve (15 of 16 cases | *[[TTF-1]] +ve | ||
**Misch ''et al.'' reported: 82.8% positive (183 +ve of 221 cases).<ref name=pmid25889870>{{Cite journal | last1 = Misch | first1 = D. | last2 = Blum | first2 = T. | last3 = Boch | first3 = C. | last4 = Weiss | first4 = T. | last5 = Crolow | first5 = C. | last6 = Griff | first6 = S. | last7 = Mairinger | first7 = T. | last8 = Bauer | first8 = TT. | last9 = Kollmeier | first9 = J. | title = Value of thyroid transcription factor (TTF)-1 for diagnosis and prognosis of patients with locally advanced or metastatic small cell lung cancer. | journal = Diagn Pathol | volume = 10 | issue = | pages = 21 | month = Apr | year = 2015 | doi = 10.1186/s13000-015-0250-z | PMID = 25889870 }}</ref> | |||
**Wu ''et al.'' reported: 15 positive of 16 cases.<ref name=pmid16138374>{{Cite journal | last1 = Wu | first1 = M. | last2 = Szporn | first2 = AH. | last3 = Zhang | first3 = D. | last4 = Wasserman | first4 = P. | last5 = Gan | first5 = L. | last6 = Miller | first6 = L. | last7 = Burstein | first7 = DE. | title = Cytology applications of p63 and TTF-1 immunostaining in differential diagnosis of lung cancers. | journal = Diagn Cytopathol | volume = 33 | issue = 4 | pages = 223-7 | month = Oct | year = 2005 | doi = 10.1002/dc.20337 | PMID = 16138374 }}</ref> | |||
*CK7 -ve.<ref name=pmid10874668>{{Cite journal | last1 = Gyure | first1 = KA. | last2 = Morrison | first2 = AL. | title = Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. | journal = Mod Pathol | volume = 13 | issue = 6 | pages = 638-43 | month = Jun | year = 2000 | doi = 10.1038/modpathol.3880111 | PMID = 10874668 }}</ref> | *CK7 -ve.<ref name=pmid10874668>{{Cite journal | last1 = Gyure | first1 = KA. | last2 = Morrison | first2 = AL. | title = Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas. | journal = Mod Pathol | volume = 13 | issue = 6 | pages = 638-43 | month = Jun | year = 2000 | doi = 10.1038/modpathol.3880111 | PMID = 10874668 }}</ref> | ||
*CK20 -ve.<ref name=pmid10874668/> | *[[CK20]] -ve.<ref name=pmid10874668/> | ||
*Ki-67 ~80% (>50% proposed as criteria for ''large cell neuroendocrine carcinoma''<ref name=pmid25318848>{{Cite journal | last1 = Liu | first1 = SZ. | last2 = Staats | first2 = PN. | last3 = Goicochea | first3 = L. | last4 = Alexiev | first4 = BA. | last5 = Shah | first5 = N. | last6 = Dixon | first6 = R. | last7 = Burke | first7 = AP. | title = Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung. | journal = Diagn Pathol | volume = 9 | issue = | pages = 174 | month = | year = 2014 | doi = 10.1186/s13000-014-0174-z | PMID = 25318848 }}</ref>). | |||
**Useful for separating from ''atypical carcinoid'' and ''typical carcinoid''. | |||
Others: | Others: | ||
*p63 +ve in ~75-80% of the cases.<ref name=pmid15551738>{{Cite journal | last1 = Au | first1 = NH. | last2 = Gown | first2 = AM. | last3 = Cheang | first3 = M. | last4 = Huntsman | first4 = D. | last5 = Yorida | first5 = E. | last6 = Elliott | first6 = WM. | last7 = Flint | first7 = J. | last8 = English | first8 = J. | last9 = Gilks | first9 = CB. | title = P63 expression in lung carcinoma: a tissue microarray study of 408 cases. | journal = Appl Immunohistochem Mol Morphol | volume = 12 | issue = 3 | pages = 240-7 | month = Sep | year = 2004 | doi = | PMID = 15551738 }}</ref> | *[[p63]] +ve in ~75-80% of the cases.<ref name=pmid15551738>{{Cite journal | last1 = Au | first1 = NH. | last2 = Gown | first2 = AM. | last3 = Cheang | first3 = M. | last4 = Huntsman | first4 = D. | last5 = Yorida | first5 = E. | last6 = Elliott | first6 = WM. | last7 = Flint | first7 = J. | last8 = English | first8 = J. | last9 = Gilks | first9 = CB. | title = P63 expression in lung carcinoma: a tissue microarray study of 408 cases. | journal = Appl Immunohistochem Mol Morphol | volume = 12 | issue = 3 | pages = 240-7 | month = Sep | year = 2004 | doi = | PMID = 15551738 }}</ref> | ||
==Sign out== | ==Sign out== | ||
===Biopsy=== | |||
<pre> | <pre> | ||
Lung, Left Lower Lobe, Core Biopsy: | Lung, Left Lower Lobe, Core Biopsy: | ||
| Line 112: | Line 117: | ||
</pre> | </pre> | ||
===Block letters=== | ====Possible LCNEC==== | ||
<pre> | |||
Lung, Left Lower Lobe, Core Biopsy: | |||
- NON–SMALL CELL CARCINOMA WITH NEUROENDOCRINE (NE) MORPHOLOGY AND POSITIVE NE MARKERS, POSSIBLE LARGE CELL NEUROENDOCRINE CARCINOMA (LCNEC). | |||
</pre> | |||
Note: | |||
*The above is the wording recommended by 2011 ATS/ERS/IASLC panel.<ref>{{cite journal |authors=Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger K, Yatabe Y, Ishikawa Y, Wistuba I, Flieder DB, Franklin W, Gazdar A, Hasleton PS, Henderson DW, Kerr KM, Petersen I, Roggli V, Thunnissen E, Tsao M |title=Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification |journal=Arch Pathol Lab Med |volume=137 |issue=5 |pages=668–84 |date=May 2013 |pmid=22970842 |pmc=4509741 |doi=10.5858/arpa.2012-0263-RA |url=}}</ref> | |||
====Block letters==== | |||
<pre> | <pre> | ||
LOWER LOBE OF LUNG, LEFT, CORE BIOPSY: | LOWER LOBE OF LUNG, LEFT, CORE BIOPSY: | ||
| Line 131: | Line 145: | ||
NEGATIVE: chromogranin A, CK5/6, TTF-1, napsin A. | NEGATIVE: chromogranin A, CK5/6, TTF-1, napsin A. | ||
</pre> | </pre> | ||
====Micro==== | |||
The sections show large cells epithelioid cells (~3-4x the size of a lymphocyte) with salt and pepper chromatin, scant basophilic cytoplasm, and focally streaming. Mitotic activity is brisk and multifocal zonal necrosis is present. | |||
==See also== | ==See also== | ||